AIM ImmunoTech (AIM) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts AIM Hot Sheet
Price: $0.16 --0%
EPS Growth %: +90.4%
Financial Fact:
Cost of sales: 4.64M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: +90.4%
Financial Fact:
Cost of sales: 4.64M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($0.03), $0.10 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ESAB Corporation (ESAB) Misses Q3 EPS by 3c ; Offers Guidance
- Acushnet (GOLF) Misses Q3 EPS by 15c; Offers Guidance
- Taboola (TBLA) Reports In-Line Q3 EPS ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
